Table 2.
Patient | Gender/Age | Adenoma | Adenocarcinoma | Stage/TNM | LVI | Location |
---|---|---|---|---|---|---|
p2 | M/65 | TA | A | I/pT2N0M0 | Y | L |
p4 | M/55 | TA | A | IIA/pT3N0M0 | N | L |
p5 | F/58 | SA | A | IIA/pT3N0M0 | Y | L |
p6 | M/64 | TA | - | - | N | L |
p7 | M/58 | TA | - | - | N | L |
p10 | F/56 | TA | A | IIA/pT3N0M0 | Y | R |
p11 | M/58 | TA | - | - | N | L |
p12 | M/60 | TA | - | - | N | L |
p13 | M/61 | TA | - | - | N | L |
p13_2 | M/61 | SA | - | - | N | L |
p14 | M/66 | TA | A | IIA/pT3N0M0 | N | L |
M = male, F = female, TA = Tubular adenoma, SA = Serrated adenoma, A = adenocarcinoma, L = left, R = right, LVI = Lymphovascular Invasion, Y = Yes, N = No.